Physician profile
Howard B Adelson
NPI 1982691739
$1,692.77
in general payments reported to CMS, 2019-2025
20 companies · $434 in 2025
The $434 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $174 · 2020: $51.45 · 2021: $297 · 2022: $343 · 2023: $163 · 2024: $229 · 2025: $434.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $827.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $826.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $310.77 | 2021-2025 | Argos, Clareon Panoptix Pro, Clareon |
| Glaukos Corporation | $233.27 | 2019-2022 | |
| Kala Pharmaceuticals, INC. | $229.36 | 2019-2022 | |
| Ocular Therapeutix, INC. | $207.60 | 2024-2025 | Dextenza |
| New World Medical,INC. | $129.66 | 2023-2025 | Clearpath, Streamline, Kahook Dual Blade |
| Dompe US, INC. | $98.03 | 2022-2025 | Oxervate |
| Abbvie INC. | $89.59 | 2022-2024 | |
| Rxsight INC | $56.56 | 2022-2023 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Oyster Point Pharma, INC. | $55.55 | 2022-2023 | Tyrvaya |
| Eyevance Pharmaceuticals LLC | $35.80 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $34.52 | 2019-2021 | |
| Tearlab Corp | $32.15 | 2023 | Tearlab Osmolarity System |
| Sun Pharmaceutical Industries INC. | $30.36 | 2025 | |
| Harrow Eye, LLC | $27.41 | 2025 | Iheezo |
| Tarsus Pharmaceuticals, INC. | $26.86 | 2025 | Xdemvy |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $22.74 | 2021 | |
| Bausch & Lomb Americas INC. | $20.08 | 2025 | Envista Envy Iol |
| Novartis Pharmaceuticals Corporation | $19.01 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $16.76 | 2024 | Tecnis Iol |
| Sight Sciences, INC. | $16.69 | 2023 | Tearcare System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Adelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.